WebChemotherapy-induced thrombocytopenia and platelet transfusion in patients with diffuse large B-cell lymphoma Chemotherapy-induced thrombocytopenia and platelet transfusion in patients with diffuse large B-cell lymphoma . 2024 Mar;9 (3):1640-1651. doi: 10.21037/tcr.2024.01.64. Authors Rong Lu 1 , Qiaoyan Lin 1 , Shan Chen 1 , Xianren Ye … WebThrombopoietin administered during induction chemotherapy to patients with acute myeloid leukemia induces transient morphologic changes that may resemble chronic …
Romiplostim: Uses, Dosage, Side Effects, Warning - Drugs.com
Web10 aug. 2024 · (4) It is administered by subcutaneous injection. The US Food and Drug Administration approved romiplostim (Nplate®) in 2008 for the treatment of low blood … Web16 aug. 2024 · Nplate is a prescription medicine used to treat low platelet counts that can lead to bleeding in people with chronic immune thrombocytopenic purpura (ITP). … human race final stand
Romiplostim for management of chemotherapy-induced …
Web31 aug. 2012 · I. To determine if Nplate (romiplostim) is capable of increasing platelet counts to > 50 x 10^9/L for greater than 2 weeks in myeloma patients with chemotherapy induced thrombocytopenia. SECONDARY OBJECTIVES: I. To evaluate the toxicity of romiplostim in this patient population by standard Common Toxicity Criteria (CTC). II. WebNplate is used when treatment with medicines such as corticosteroids or immunoglobulins has not worked. Nplate can be used in patients whose spleen has been removed to … Web14 mrt. 2014 · Inclusion Criteria: Eligible subjects will be currently pregnant women residing in the US who: Have had any exposure to Nplate® at any time during the pregnancy, which is defined as the period between first day of the last menstrual period (LMP) (ie, within two weeks of conception) up to any date before the date of delivery or end of the pregnancy. human race flag